These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 33221787

  • 1. Blood pressure control and kidney damage in hypertension: Results of a three-center cross-sectional study in North Central Nigeria.
    Abene EE, Gimba ZM, Edah JO, Akinbuwa BA, Uchendu DG, Onyenuche C, Ojo OS, Tzamaloukas AH, Agaba EI.
    Niger J Clin Pract; 2020 Nov; 23(11):1590-1597. PubMed ID: 33221787
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of chronic kidney disease and risk factors in North-Central Nigeria: a population-based survey.
    Olanrewaju TO, Aderibigbe A, Popoola AA, Braimoh KT, Buhari MO, Adedoyin OT, Kuranga SA, Biliaminu SA, Chijioke A, Ajape AA, Grobbee DE, Blankestijn PJ, Klipstein-Grobusch K, Ilorin Renal Study Group.
    BMC Nephrol; 2020 Nov 10; 21(1):467. PubMed ID: 33167899
    [Abstract] [Full Text] [Related]

  • 3. Screening for chronic kidney disease in an urban population in Nigeria.
    Okafor UH, Ogbobe O, Ugwu N, Nebo C, Asogwa P.
    Ann Afr Med; 2021 Nov 10; 20(2):92-97. PubMed ID: 34213474
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pattern and predictors of urine protein excretion among patients with type 2 diabetes attending a single tertiary hospital in Lagos, Nigeria.
    Bello BT, Amira CO.
    Saudi J Kidney Dis Transpl; 2017 Nov 10; 28(6):1381-1388. PubMed ID: 29265051
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute kidney injury is a risk factor for subsequent proteinuria.
    Parr SK, Matheny ME, Abdel-Kader K, Greevy RA, Bian A, Fly J, Chen G, Speroff T, Hung AM, Ikizler TA, Siew ED.
    Kidney Int; 2018 Feb 10; 93(2):460-469. PubMed ID: 28927644
    [Abstract] [Full Text] [Related]

  • 11. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E, Sarnak MJ, Toto R, McCulloch CE, Lin F, Smogorzewski M, Hsu CY.
    J Am Heart Assoc; 2019 Aug 20; 8(16):e012749. PubMed ID: 31411082
    [Abstract] [Full Text] [Related]

  • 12. The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
    García-Prieto AM, Verdalles Ú, de José AP, Verde E, Arroyo D, Aragoncillo I, Linares T, Barbieri D, Goicoechea M.
    Hipertens Riesgo Vasc; 2020 Aug 20; 37(3):101-107. PubMed ID: 32156479
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study.
    Tannor EK, Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adu-Gyamfi R, Plange-Rhule J.
    J Clin Hypertens (Greenwich); 2019 Oct 20; 21(10):1542-1550. PubMed ID: 31465141
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and risk factors of chronic kidney disease in newly diagnosed and untreated hypertensive patients in cameroon: A cross-sectional study.
    Kamdem F, Lekpa FK, Doualla MS, Nouga YN, Sontsa OD, Temfack E, Kingue S.
    Saudi J Kidney Dis Transpl; 2017 Oct 20; 28(5):1144-1149. PubMed ID: 28937076
    [Abstract] [Full Text] [Related]

  • 15. CKD awareness and blood pressure control in the primary care hypertensive population.
    Ravera M, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Am J Kidney Dis; 2011 Jan 20; 57(1):71-7. PubMed ID: 21087817
    [Abstract] [Full Text] [Related]

  • 16. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
    Xue C, Zhou C, Yang B, Lv J, Dai B, Yu S, Wang Y, Zhao G, Mei C.
    BMJ Open; 2017 Feb 24; 7(2):e013672. PubMed ID: 28237959
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of Kidney Dysfunction and Associated Risk Factors in a Southwestern City in Nigeria: A Cross-Sectional Study.
    Adejumo OA, Junaid OA, Egbi OG, Edeki IR, Oyedepo DS, Fabusuyi O, Akinyosoye GO, Oloyede RO.
    West Afr J Med; 2024 Mar 29; 41(3):244-250. PubMed ID: 38785394
    [Abstract] [Full Text] [Related]

  • 18. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia.
    Damtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D, Abebe M.
    Ethiop J Health Sci; 2018 Nov 29; 28(6):691-700. PubMed ID: 30607085
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of chronic kidney disease and its risk factors among adults in a semi-urban community of South-East Nigeria.
    Okwuonu CG, Chukwuonye II, Adejumo OA, Agaba EI, Ojogwu LI.
    Niger Postgrad Med J; 2017 Nov 29; 24(2):81-87. PubMed ID: 28762361
    [Abstract] [Full Text] [Related]

  • 20. The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
    Yanagi M, Tamura K, Fujikawa T, Wakui H, Kanaoka T, Ohsawa M, Azushima K, Maeda A, Kobori H, Umemura S.
    Hypertens Res; 2013 Mar 29; 36(3):262-9. PubMed ID: 23154587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.